GlassScriptPhysician profile
Ahmed Mamilly
NPI 1043599509
$1,873.88
in general payments reported to CMS, 2019-2025
10 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.87 · 2022: $1,261 · 2023: $382 · 2024: $20.96 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,032.83 | 2021-2022 | |
| Inari Medical, INC. | $350.05 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $240.76 | 2022 | |
| Boston Scientific Corporation | $138.49 | 2025 | Embold Fibered |
| Becton, Dickinson and Company | $23.94 | 2025 | Pleurx |
| Argon Medical Devices, INC. | $20.96 | 2024 | Clot Management |
| Ge Healthcare | $17.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.16 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2023 | |
| Angiodynamics, INC. | $16.04 | 2023 | Smart Port Ct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Mamilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.